These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 9816218)

  • 1. Immunization of melanoma patients with BEC2 anti-idiotypic monoclonal antibody that mimics GD3 ganglioside: enhanced immunogenicity when combined with adjuvant.
    McCaffery M; Yao TJ; Williams L; Livingston PO; Houghton AN; Chapman PB
    Clin Cancer Res; 1996 Apr; 2(4):679-86. PubMed ID: 9816218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential immunization of melanoma patients with GD3 ganglioside vaccine and anti-idiotypic monoclonal antibody that mimics GD3 ganglioside.
    Chapman PB; Wu D; Ragupathi G; Lu S; Williams L; Hwu WJ; Johnson D; Livingston PO
    Clin Cancer Res; 2004 Jul; 10(14):4717-23. PubMed ID: 15269144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunization of melanoma patients with BEC2-keyhole limpet hemocyanin plus BCG intradermally followed by intravenous booster immunizations with BEC2 to induce anti-GD3 ganglioside antibodies.
    Yao TJ; Meyers M; Livingston PO; Houghton AN; Chapman PB
    Clin Cancer Res; 1999 Jan; 5(1):77-81. PubMed ID: 9918205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A phase II trial comparing five dose levels of BEC2 anti-idiotypic monoclonal antibody vaccine that mimics GD3 ganglioside.
    Chapman PB; Williams L; Salibi N; Hwu WJ; Krown SE; Livingston PO
    Vaccine; 2004 Jul; 22(21-22):2904-9. PubMed ID: 15246627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long survival of patients with small cell lung cancer after adjuvant treatment with the anti-idiotypic antibody BEC2 plus Bacillus Calmette-Guérin.
    Grant SC; Kris MG; Houghton AN; Chapman PB
    Clin Cancer Res; 1999 Jun; 5(6):1319-23. PubMed ID: 10389914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccinating against GD3 ganglioside using BEC2 anti-idiotypic monoclonal antibody.
    Chapman PB
    Curr Opin Investig Drugs; 2003 Jun; 4(6):710-5. PubMed ID: 12901230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of IgG antibodies against GD3 ganglioside in rabbits by an anti-idiotypic monoclonal antibody.
    Chapman PB; Houghton AN
    J Clin Invest; 1991 Jul; 88(1):186-92. PubMed ID: 2056117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of antibodies against GM2 ganglioside by immunizing melanoma patients using GM2-keyhole limpet hemocyanin + QS21 vaccine: a dose-response study.
    Chapman PB; Morrissey DM; Panageas KS; Hamilton WB; Zhan C; Destro AN; Williams L; Israel RJ; Livingston PO
    Clin Cancer Res; 2000 Mar; 6(3):874-9. PubMed ID: 10741710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The idiotype (Id) cascade in mice elicited the production of anti-R24 Id and anti-anti-Id monoclonal antibodies with antitumor and protective activity against human melanoma.
    Ramos AS; Parise CB; Travassos LR; Han SW; de Campos-Lima PO; de Moraes JZ
    Cancer Sci; 2011 Jan; 102(1):64-70. PubMed ID: 21070480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
    Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
    Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation by adjuvants and carriers of the immunogenicity in xenogeneic hosts of mouse anti-idiotypic monoclonal antibody MK2-23, an internal image of human high molecular weight-melanoma associated antigen.
    Chen ZJ; Yang H; Liu CC; Hirai S; Ferrone S
    Cancer Res; 1993 Jan; 53(1):112-9. PubMed ID: 8416734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase III study of adjuvant vaccination with Bec2/bacille Calmette-Guerin in responding patients with limited-disease small-cell lung cancer (European Organisation for Research and Treatment of Cancer 08971-08971B; Silva Study).
    Giaccone G; Debruyne C; Felip E; Chapman PB; Grant SC; Millward M; Thiberville L; D'addario G; Coens C; Rome LS; Zatloukal P; Masso O; Legrand C
    J Clin Oncol; 2005 Oct; 23(28):6854-64. PubMed ID: 16192577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody responses in melanoma patients immunized with an anti-idiotype antibody mimicking disialoganglioside GD2.
    Foon KA; Sen G; Hutchins L; Kashala OL; Baral R; Banerjee M; Chakraborty M; Garrison J; Reisfeld RA; Bhattacharya-Chatterjee M
    Clin Cancer Res; 1998 May; 4(5):1117-24. PubMed ID: 9607568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human high molecular weight-melanoma associated antigen mimicry by an anti-idiotypic antibody: characterization of the immunogenicity and the immune response to the mouse monoclonal antibody IMel-1.
    Chattopadhyay P; Kaveri SV; Byars N; Starkey J; Ferrone S; Raychaudhuri S
    Cancer Res; 1991 Nov; 51(22):6045-51. PubMed ID: 1933867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of a human anti-idiotypic antibody that mimics the GD2 antigen.
    Saleh MN; Stapleton JD; Khazaeli MB; LoBuglio AF
    J Immunol; 1993 Sep; 151(6):3390-8. PubMed ID: 8376782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Response in patients with melanoma to immunization using melanoma oncolysates of vaccine virus].
    Doré JF; Portoukalian J; Berthier-Vergnes O; Jacubovich R; Genève J; Bailly M; Lefthériotis E; Weissbrod A; Mayer M
    Bull Cancer; 1990; 77(9):881-91. PubMed ID: 2224160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GM2-KLH conjugate vaccine: increased immunogenicity in melanoma patients after administration with immunological adjuvant QS-21.
    Helling F; Zhang S; Shang A; Adluri S; Calves M; Koganty R; Longenecker BM; Yao TJ; Oettgen HF; Livingston PO
    Cancer Res; 1995 Jul; 55(13):2783-8. PubMed ID: 7796403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to immunization with purified GD3 ganglioside and GD3 derivatives (lactones, amide and gangliosidol) in the mouse.
    Ritter G; Boosfeld E; Calves MJ; Oettgen HF; Old LJ; Livingston PO
    Immunobiology; 1990 Dec; 182(1):32-43. PubMed ID: 2098322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human high molecular weight melanoma-associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: enhancement of immunogenicity of anti-idiotypic monoclonal antibody MK2-23 by fusion with interleukin 2.
    Wang X; Ko EC; Peng L; Gillies SD; Ferrone S
    Cancer Res; 2005 Aug; 65(15):6976-83. PubMed ID: 16061683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of therapeutic and immunologic effects of R(24) anti-GD3 monoclonal antibody in 37 patients with metastatic melanoma.
    Kirkwood JM; Mascari RA; Edington HD; Rabkin MS; Day RS; Whiteside TL; Vlock DR; Shipe-Spotloe JM
    Cancer; 2000 Jun; 88(12):2693-702. PubMed ID: 10870051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.